Re:AstraZeneca unveils successes in treatment of lung cancer
by jncfhnb on Monday February 19, 2024 @02:52PM
(#39433944)
You are, again, failing to note that it’s a right skewed distribution. The mean is not what you care about.
[ Parent
| on HN ]
Re:AstraZeneca unveils successes in treatment of lung cancer
by s1artibartfast on Monday February 19, 2024 @03:18PM
(#39434286)
To be fair, the Improvement for the tail is pretty Grim too. We have 'only' seen 5 year survival improve from 0.7% in 1973 to 3.2% in 2010.
I think the skewed distribution is less relevant than the sample group. There are limits to what we can expect from medicine. We don't have improved survival after decapitation, but that doesn't mean surgery has been at a standstill.
It would be interesting to look up survival rates for earlier stages. I expect the difference would be more substantial.
Re:AstraZeneca unveils successes in treatment of lung cancer
by pauln99 on Monday February 19, 2024 @03:11PM
(#39434194)
In fairness, I was responding to the first sentence in the quote from the article.
It seems relevant, as a patient to ask, on average, how much longer will I live if I take this drug?
Re:AstraZeneca unveils successes in treatment of lung cancer
by s1artibartfast on Monday February 19, 2024 @03:25PM
(#39434371)
To which, an average is a pretty poor way to convey non-normal data.
If you run a year long trial where you flip a coin and immediately kill or save people based on the results, your average survival will be 6 months